My research uses the concepts and methods of behavioral economics and behavioral pharmacology to investigate tobacco, illicit drugs, and other health-related risk behaviors in vulnerable populations. Projects focus on examining mechanisms underpinning vulnerability to tobacco and other risk behaviors, treatment interventions to reduce them and improve health outcomes, and regulatory science.

These projects are supported by P20 and P50 center grants from the NIH’s National Institute on General Medical Sciences, the Food and Drug Administration, and the National Institute on Drug Abuse, respectively, and an R01 research grant from the National Institute of Child Health and Human Development.